Given that the interaction of LSEC with NKT cells has not been validated using tissue samples of patients with HCC, we dissected 53,982 human single-cell transcriptomes to explore the feasibility of targeting the LSEC-CXCL16/CXCR6+ NKT cells axis in humans. This evidence concerns the gene CXCL16 and hepatocellular carcinoma.